InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the detailed record of transactions filed by Clayman Michael D., Chief Executive Officer. Officer active across 1 companies, notably Flexion Therapeutics Inc. Aggregated, 6 filings have been logged. The latest transaction was filed on 19 November 2021 — Disposition. Regulator: SEC (Form 4). All data is accessible without signup.
Declarations6 total
€3m335,498 shares@ €7.476999.6% of flow
Common Stock
SEC:0001209191-21-065703·
€3m335,498 shares@ €7.476949.8% of flow
Common Stock
SEC:0001209191-21-065703:0·
13,859 shares
Common Stock
SEC:0001209191-21-047501·
13,859 shares
Common Stock
SEC:0001209191-21-047501:0·
€11,1031,700 shares@ €6.53090.4% of flow
Common Stock
SEC:0001209191-21-043522·
€11,1031,700 shares@ €6.53090.2% of flow
Common Stock
SEC:0001209191-21-043522:0·
6 of 6 declarations
About Clayman Michael D.
Michael D. Clayman is the President and Chief Executive Officer of Flexion Therapeutics Inc. He leads the company with a strategic vision focused on innovation and service improvement. His experience in the pharmaceutical sector enables him to guide the company in a constantly evolving environment. He is committed to providing quality solutions to clients.
